Complete remission of brain metastases in non-small cell lung cancer patients harboring an EGFR mutation treated with tyrosine kinase inhibitor without radiotherapy: A report of 3 cases

Case Reports in Oncology

Volumn 7, Issue 1, 2014, Pages 149-154

  Jung, Yun Hwa ^a   Han, Chi Wha ^a   Jung, Yun Duk ^a   Cho, Young Yun ^a   Han, Deok Jae ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Brain metastases; Non small cell lung cancer; Tyrosine kinase inhibitor; Whole brain radiotherapy

Indexed keywords

CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; THYROID TRANSCRIPTION FACTOR 1;

ADULT; AGED; ARTICLE; BACKACHE; BRAIN DAMAGE; BRAIN METASTASIS; BRONCHOSCOPIC BIOPSY; BRONCHUS BIOPSY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CEREBELLUM; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EXON; FEMALE; FOLLOW UP; GENE DELETION; HEMISPHERE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUMBAR SPINE; LUMBAR VERTEBRA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MEDIASTINAL LYMPHADENOPATHY; MEDICAL HISTORY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PELVIC GIRDLE; POINT MUTATION; PRIORITY JOURNAL; RADIOTHERAPY; SMOKING; SPINE METASTASIS; SUPRACLAVICULAR LYMPHADENOPATHY; THORAX RADIOGRAPHY; TREATMENT DURATION; WHOLE BODY PET; WHOLE BRAIN RADIOTHERAPY;

EID: 84900520468     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000360731     Document Type: Article

References (16)

1. Schwer AL, Gaspar LE: Update in the treatment of brain metastases from lung cancer. Clin Lung Cancer 2006;8:180-186.
2. Kim JE, Lee DH, Choi Y, et al: Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis. Lung Cancer 2009;65:351-354.
3. Muller F, Riesenberg H, Hirmle P, Gehl HB, Duwel P, Gorner M: Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy. Strahlenther Onkol 2011;187:826-830.
4. Park SJ, Kim HT, Lee DH, et al: Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation. Lung Cancer 2012;77:556-560.
5. Berger LA, Riesenberg H, Bokemeyer C, Atanackovic D: CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives. Lung Cancer 2013;80:242-248.
6. Zeng YD, Zhang L, Liao H, et al: Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell-lung cancer: a retrospective study. Asian Pac J Cancer Prev 2012;13:909-914.
7. Iuchi T, Shingyoji M, Sakaida T, et al: Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR mutant lung adenocarcinoma. Lung Cancer 2013;82:282-287.
8. Welsh JW, Komaki R, Amini A, et al: Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer. J Clin Oncol 2013;31:895-902.
9. McDuff SG, Taich ZJ, Lawson JD, et al: Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. J Neurol Neurosurg Psychiatry 2013;84:1384-1391.
10. Sun A, Bae K, Gore EM, et al: Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: Neurocognitive and quality-of-life analysis. J Clin Oncol 2011;29:279-286.
11. Shar MG, Ball DL: Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy. Curr Treat Options Oncol 2013;14:553-567.
12. Hirata H, Nakamura K, Kunitake N, et al: Association between EGFR-TKI resistance and efficacy of radiotherapy for brain metastases from EGFR-mutant lung adenocarcinoma. Anticancer Res 2013;33: 1649-1655.
13. Katayama T, Shimizu J, Suda K, et al: Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib. J Thorac Oncol 2009;11:1415-1419.
14. Yu Ha, Sima CS, Huana J, et al: Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors. J Thorac Oncol 2013;8:346-351.
15. Zhao J, Chen M, Zhong W, et al: Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinoma. Clin Lung Cancer 2013;14:188-193.
16. Zhuang H, Yuan Z, Wang J, Zhao L, Pang Q, Wang P: Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma. Drug Des Devel Ther 2013;8:1179-1186.